charlie
Frequent Contributor (1K+ posts)
Member # 25
posted
Jenny wrote him about this matter and I'm frankly too lazy to wade thru politico-speak so maybe you can all chew on this if you like. At least he responded which I see as a positive...
Thank you for contacting me about the Food and Drug Administration Revitalization Act (S. 1082). I appreciate having the benefit of your comments on this important matter.
As you may know, Senator Edward Kennedy introduced S. 1082 on April 10, 2007. This legislation would amend the Federal Food, Drug, and Cosmetic Act and would overhaul the Food and Drug Administration's procedures for ensuring prescription drug and medical device safety. S. 1082 would also preserve and strengthen the FDA's ability to get prescription drugs to the market quickly. The prescription-drug user fee provision is a key component of this legislation, as it would provide the FDA with resources to improve and modernize its drug-safety monitoring system. I voted for this legislation, which the Senate passed on May 9, 2007, by a vote of 93 to 1.
Senator Byron Dorgan introduced an amendment that would allow the importation of prescription drugs. As a result, Senator Thad Cochran proposed an amendment (S. AMDT. 1010) that would allow the prescription drug importation proposed in the Dorgan amendment only if the Department of Health and Human Services first certifies that the importation would not pose an additional health and safety risk and would lead to reduced prescription drug costs for U.S. consumers.
I supported the Cochran amendment, which passed the Senate by a vote of 49 to 40, because we must ensure that imported drugs are safe. Allowing drug importation outside the FDA's current safety system without addressing safety concerns could threaten public health and result in unsafe, unapproved, and counterfeit drugs being imported into the United States.
Additionally, I supported the amendment offered by Senator Pat Roberts that would repeal the drug advertising ban and substitute an effective advertisement-monitoring system that ensures ads are truthful and not misleading. This amendment would also give the FDA the authority to impose a maximum $150,000 fine for false or misleading ads.
This legislation addresses prescription drugs and medical devices and does not change the existing laws that govern dietary supplements and vitamins. In fact, it is important to note that the Food, Drug, and Cosmetic Act--the piece of legislation which sets forth guidelines about dietary supplements and vitamins--does not place prescription drugs and medical devices in the same category as supplements and vitamins.
I appreciate having the opportunity to represent the interests of Texans in the United States Senate. Thank you for taking the time to contact me.
Sincerely,
JOHN CORNYN United States Senator
517 Hart Senate Office Building Washington, DC 20510 Tel: (202) 224-2934 Fax: (202) 228-2856 http://www.cornyn.senate.govPosts: 2804 | From Texas | Registered: Oct 2000
| IP: Logged |
bettyg
Unregistered
posted
sounds like same form letter i got from iowa sen!
IP: Logged |
MagicAcorn
Frequent Contributor (1K+ posts)
Member # 8786
posted
I think it is good that they respond to their constituents. Probably is somewhat of a form letter but think how much mail they get each day.
Remember even if you don't get a really personal letter back in response to yours, the subject of your letter still got across.
-------------------- The best index to a person's character is how he treats people who can't do him any good, and how he treats people who can't fight back. -Abigail van Buren (Pauline Esther Friedman) (1918-2002) Posts: 409 | From Florida | Registered: Dec 2005
| IP: Logged |
The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:
The
Lyme Disease Network of New Jersey 907 Pebble Creek Court,
Pennington,
NJ08534USA http://www.lymenet.org/